A-Level生物 抗生素 耐药机制 抗菌药物

A-Level Biology: Antibiotics and Antimicrobial Resistance ： Mechanisms, Targets, and the Global Challenge

1. Introduction to Antibiotics

Antibiotics are chemical compounds produced by microorganisms (or synthesised artificially) that kill or inhibit the growth of bacteria. They are one of the most significant medical discoveries of the 20th century, transforming previously fatal bacterial infections into treatable conditions. The term “antibiotic” originally referred only to naturally derived compounds, but now encompasses semi-synthetic and fully synthetic antimicrobial agents as well. 抗生素是由微生物产生（或人工合成）的化合物，能够杀死或抑制细菌的生长。它们是20世纪最重要的医学发现之一，将曾经致命的细菌感染转变为可治疗的疾病。”抗生素”一词最初仅指天然来源的化合物，但现在也包括半合成和全合成的抗菌药物。

Antibiotics can be classified as bactericidal (killing bacteria directly) or bacteriostatic (inhibiting bacterial growth, allowing the host immune system to eliminate the infection). The distinction is important clinically: bactericidal drugs are preferred for life-threatening infections such as meningitis and endocarditis, while bacteriostatic agents are effective when the immune system is competent. The minimum inhibitory concentration (MIC) is the lowest concentration of an antibiotic that prevents visible bacterial growth and is a key measure of antibiotic potency. 抗生素可分为杀菌性（直接杀死细菌）和抑菌性（抑制细菌生长，让宿主免疫系统清除感染）。这一区分在临床上很重要：对于脑膜炎和心内膜炎等危及生命的感染，优先使用杀菌性药物，而抑菌性药物在免疫系统功能正常时同样有效。最低抑菌浓度（MIC）是抗生素阻止细菌可见生长的最低浓度，是衡量抗生素效力的关键指标。

2. Mechanisms of Antibiotic Action: An Overview

Antibiotics exploit differences between bacterial and eukaryotic cells to achieve selective toxicity ： the ability to harm bacteria without damaging the host. There are five major targets of antibiotic action in bacterial cells: cell wall synthesis, protein synthesis, nucleic acid synthesis, metabolic pathways, and cell membrane integrity. Each class of antibiotics targets one or more of these essential bacterial processes. 抗生素利用细菌细胞与真核细胞之间的差异来实现选择性毒性：即在不伤害宿主的情况下损伤细菌的能力。细菌细胞中有五个主要的抗生素作用靶点：细胞壁合成、蛋白质合成、核酸合成、代谢途径和细胞膜完整性。每一类抗生素都针对其中一个或多个关键的细菌生理过程。

Selective toxicity is the cornerstone of antibiotic therapy. For example, penicillins target peptidoglycan synthesis ： a structure unique to bacterial cell walls that is absent in human cells. Similarly, antibiotics that inhibit bacterial ribosomes (70S) generally spare human ribosomes (80S), although some cross-reactivity with mitochondrial ribosomes (which are also 70S) can cause side effects. Understanding these molecular targets is essential for A-Level biology students, as it connects fundamental concepts in cell biology to practical medicine. 选择性毒性是抗生素治疗的基础。例如，青霉素靶向肽聚糖合成：这是细菌细胞壁独有的结构，在人类细胞中不存在。同样，抑制细菌核糖体（70S）的抗生素通常不作用于人类核糖体（80S），但与线粒体核糖体（也是70S）的交叉反应可能会引起副作用。理解这些分子靶点对A-Level生物学生至关重要，因为它将细胞生物学的基本概念与实际医学联系起来。

3. Cell Wall Synthesis Inhibitors

The bacterial cell wall is composed of peptidoglycan (murein), a polymer of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) residues, cross-linked by short peptide chains. This rigid structure maintains cell shape and resists osmotic pressure. Beta-lactam antibiotics, including penicillins and cephalosporins, inhibit transpeptidase enzymes (also known as penicillin-binding proteins) that catalyse the cross-linking of peptidoglycan strands. Without proper cross-linking, the cell wall weakens, and the bacterium bursts due to osmotic lysis. 细菌细胞壁由肽聚糖（胞壁质）组成：一种由N-乙酰葡糖胺（NAG）和N-乙酰胞壁酸（NAM）残基交替排列、通过短肽链交联而成的聚合物。这种刚性结构维持细胞形状并抵抗渗透压。β-内酰胺类抗生素，包括青霉素和头孢菌素，抑制催化肽聚糖链交联的转肽酶（也称为青霉素结合蛋白）。没有正常的交联，细胞壁变弱，细菌因渗透性裂解而破裂。

Glycopeptide antibiotics such as vancomycin work by a different mechanism: they bind directly to the D-Ala-D-Ala terminus of the peptide side chains, physically blocking transpeptidation. Vancomycin is often reserved for serious infections caused by Gram-positive bacteria resistant to beta-lactams, such as MRSA (methicillin-resistant Staphylococcus aureus). Other cell wall inhibitors include bacitracin (blocks peptidoglycan precursor transport) and fosfomycin (inhibits the first step of peptidoglycan synthesis). 糖肽类抗生素如万古霉素以不同的机制起作用：它们直接与肽侧链的D-Ala-D-Ala末端结合，物理性地阻断转肽反应。万古霉素通常保留用于由对β-内酰胺类耐药的革兰氏阳性菌引起的严重感染，如MRSA（耐甲氧西林金黄色葡萄球菌）。其他细胞壁抑制剂包括杆菌肽（阻断肽聚糖前体运输）和磷霉素（抑制肽聚糖合成的第一步）。

4. Protein Synthesis Inhibitors

Bacterial ribosomes (70S) consist of a 50S large subunit and a 30S small subunit, differing from eukaryotic 80S ribosomes. This structural difference allows antibiotics to selectively target bacterial protein synthesis. Several major antibiotic classes exploit this target. Tetracyclines bind to the 30S subunit and block the attachment of aminoacyl-tRNA to the A site, preventing the elongation of the polypeptide chain. Doxycycline and minocycline are widely used tetracyclines effective against a broad spectrum of bacteria. 细菌核糖体（70S）由50S大亚基和30S小亚基组成，与真核生物的80S核糖体不同。这种结构差异使抗生素能够选择性地靶向细菌蛋白质合成。几个主要的抗生素类别利用了这一靶点。四环素类与30S亚基结合，阻断氨基酰-tRNA附着到A位点，阻止多肽链的延伸。多西环素和米诺环素是广谱有效的常用四环素类药物。

Macrolides, including erythromycin, clarithromycin, and azithromycin, bind to the 50S subunit and block the exit tunnel through which the nascent polypeptide emerges. This causes premature dissociation of the peptidyl-tRNA and halts translation. Aminoglycosides such as gentamicin and streptomycin also bind to the 30S subunit but cause misreading of mRNA codons, leading to the production of non-functional proteins. Chloramphenicol and linezolid target the 50S subunit at the peptidyl transferase centre, blocking peptide bond formation. 大环内酯类，包括红霉素、克拉霉素和阿奇霉素，与50S亚基结合，阻断新生多肽链穿出的出口通道。这导致肽基-tRNA提前解离并终止翻译。氨基糖苷类如庆大霉素和链霉素也结合30S亚基，但导致mRNA密码子误读，产生无功能的蛋白质。氯霉素和利奈唑胺靶向50S亚基的肽基转移酶中心，阻断肽键形成。

5. Nucleic Acid Synthesis Inhibitors

Antibiotics that interfere with DNA replication or RNA transcription exploit differences between bacterial and eukaryotic enzymes. Quinolones and fluoroquinolones (e.g., ciprofloxacin, levofloxacin) inhibit DNA gyrase (topoisomerase II) and topoisomerase IV ： enzymes essential for bacterial DNA supercoiling, replication, and chromosome segregation. By trapping these enzymes on DNA as cleavage complexes, fluoroquinolones generate double-strand breaks that are lethal to bacteria. 干扰DNA复制或RNA转录的抗生素利用了细菌和真核生物酶之间的差异。喹诺酮类和氟喹诺酮类（如环丙沙星、左氧氟沙星）抑制DNA旋转酶（拓扑异构酶II）和拓扑异构酶IV：这些酶对细菌DNA的超螺旋化、复制和染色体分离至关重要。氟喹诺酮类通过将这些酶捕获在DNA上形成裂解复合物，产生对细菌致命的双链断裂。

Rifamycins, most notably rifampicin, inhibit bacterial RNA polymerase by binding to the beta subunit of the enzyme, blocking the initiation of transcription. Rifampicin is a cornerstone of tuberculosis treatment, used in combination with other drugs to prevent resistance development. Metronidazole works through a distinct mechanism: it is reduced inside anaerobic bacteria to form toxic radicals that damage DNA, making it effective against anaerobic infections but inactive against aerobic organisms. 利福霉素类，尤其是利福平，通过与细菌RNA聚合酶的β亚基结合来抑制该酶，阻断转录起始。利福平是结核病治疗的基石，与其他药物联合使用以防止耐药性产生。甲硝唑通过独特的机制起作用：它在厌氧菌内被还原形成损伤DNA的有毒自由基，使其对厌氧感染有效但对需氧菌无活性。

6. Metabolic Pathway Inhibitors (Antimetabolites)

Some antibiotics function as antimetabolites, structurally resembling essential substrates and competitively inhibiting key enzymes in bacterial metabolic pathways. Sulfonamides (sulfa drugs) are structural analogues of para-aminobenzoic acid (PABA), a precursor in the bacterial synthesis of folic acid. By competitively inhibiting dihydropteroate synthase, sulfonamides block folic acid production ： a vitamin essential for nucleotide and amino acid synthesis. Humans obtain folic acid from their diet, so this pathway is selectively toxic to bacteria. 某些抗生素作为抗代谢物发挥作用，在结构上模拟必需底物，竞争性抑制细菌代谢途径中的关键酶。磺胺类药物是对氨基苯甲酸（PABA）的结构类似物，PABA是细菌合成叶酸的前体。通过竞争性抑制二氢蝶酸合酶，磺胺类药物阻断叶酸的产生：叶酸是核苷酸和氨基酸合成所必需的维生素。人类从饮食中获取叶酸，因此该途径对细菌具有选择性毒性。

Trimethoprim inhibits a later step in the same pathway, blocking dihydrofolate reductase (DHFR) and preventing the conversion of dihydrofolate to tetrahydrofolate. Sulfonamides and trimethoprim are often combined (co-trimoxazole) to achieve synergistic bactericidal activity through sequential blockade of the same pathway. This combination also reduces the likelihood of resistance, as a bacterium would need to acquire mutations in two separate enzymes simultaneously. 甲氧苄啶抑制同一途径中更下游的步骤，阻断二氢叶酸还原酶（DHFR），阻止二氢叶酸转化为四氢叶酸。磺胺类药物和甲氧苄啶通常联合使用（复方新诺明），通过对同一途径的序贯阻断实现协同杀菌活性。这种组合也降低了耐药性的可能性，因为细菌需要同时在两个不同的酶中获得突变。

7. Mechanisms of Antimicrobial Resistance

Antimicrobial resistance (AMR) occurs when bacteria evolve mechanisms that protect them from the effects of antibiotics. There are four principal resistance mechanisms. First, enzymatic inactivation: bacteria produce enzymes that chemically modify or destroy the antibiotic. Beta-lactamases (penicillinases, cephalosporinases, extended-spectrum beta-lactamases, and carbapenemases) hydrolyse the beta-lactam ring, rendering penicillins and cephalosporins ineffective. 抗微生物耐药性（AMR）是指细菌进化出保护自身免受抗生素作用的机制。主要有四种耐药机制。第一，酶促灭活：细菌产生化学修饰或破坏抗生素的酶。β-内酰胺酶（青霉素酶、头孢菌素酶、超广谱β-内酰胺酶和碳青霉烯酶）水解β-内酰胺环，使青霉素和头孢菌素失效。

Second, target site modification: mutations reduce antibiotic binding affinity while preserving the target’s normal function. MRSA has acquired the mecA gene encoding PBP2a ： an altered penicillin-binding protein with low affinity for all beta-lactams. Third, reduced permeability or increased efflux: bacteria decrease porin channel expression or upregulate efflux pumps that export antibiotics. Pseudomonas aeruginosa combines low outer-membrane permeability with multiple efflux systems. Fourth, target bypass: bacteria acquire alternative pathways that circumvent the inhibited step, as in vancomycin-resistant enterococci (VRE) which alter peptidoglycan precursors from D-Ala-D-Ala to D-Ala-D-Lac. 第二，靶点修饰：突变降低抗生素结合亲和力同时保持靶点功能。MRSA获得mecA基因编码PBP2a：一种对所有β-内酰胺类亲和力低的青霉素结合蛋白。第三，通透性降低或外排增加：细菌降低孔蛋白表达或上调外排泵。铜绿假单胞菌以低外膜通透性和多重外排系统著称。第四，靶点绕道：细菌获得绕过被抑制步骤的替代途径，如万古霉素耐药肠球菌（VRE）将肽聚糖前体从D-Ala-D-Ala改为D-Ala-D-Lac。

8. Genetic Basis of Resistance

Antibiotic resistance arises through two main genetic routes: spontaneous chromosomal mutations and horizontal gene transfer (HGT). Spontaneous mutations in genes encoding antibiotic targets, porins, efflux pumps, or regulatory proteins can confer resistance. These mutations occur at low frequencies during DNA replication but are strongly selected for when antibiotics are present. A single point mutation in the gyrA gene encoding DNA gyrase can confer fluoroquinolone resistance in E. coli. 抗生素耐药性通过两条主要遗传途径产生：自发性染色体突变和水平基因转移（HGT）。编码抗生素靶点、孔蛋白、外排泵或调节蛋白的基因中的自发突变可以赋予耐药性。这些突变在DNA复制过程中以低频率发生，但当抗生素存在时会被强烈选择。编码DNA旋转酶的gyrA基因中的单个点突变即可赋予大肠杆菌氟喹诺酮类耐药性。

Horizontal gene transfer is arguably more dangerous, as it enables the rapid spread of resistance genes between bacteria of the same or different species. Three mechanisms mediate HGT in bacteria: transformation (uptake of free DNA from the environment), transduction (transfer of DNA via bacteriophages), and conjugation (direct cell-to-cell transfer of plasmids through a sex pilus). Conjugative plasmids often carry multiple resistance genes, creating multidrug-resistant (MDR) strains. Integrons ： genetic elements that capture and express gene cassettes ： further accelerate the assembly of resistance gene clusters. 水平基因转移可以说更加危险，因为它使耐药基因能够在同种或不同种的细菌之间迅速传播。三种机制介导细菌中的HGT：转化（从环境中摄取游离DNA）、转导（通过噬菌体转移DNA）和接合（通过性菌毛直接进行细胞间的质粒转移）。接合质粒通常携带多个耐药基因，产生多重耐药（MDR）菌株。整合子：捕获和表达基因盒的遗传元件：进一步加速了耐药基因簇的组装。

9. Factors Promoting Antibiotic Resistance

The rise of antimicrobial resistance is driven by biological, behavioural, and systemic factors. Overuse and misuse of antibiotics in human medicine： prescribing for viral infections, using broad-spectrum agents unnecessarily, and patients not completing courses： creates strong selective pressure favouring resistant strains. In agriculture, antibiotic use as growth promoters in livestock and aquaculture introduces sub-therapeutic concentrations into the environment, selecting for resistance in commensal and environmental bacteria. 抗微生物耐药性的上升由生物、行为和系统性因素共同驱动。人类医学中抗生素的过度使用和误用：为病毒感染开具处方、不必要使用广谱药物、患者未完成疗程：产生了有利于耐药菌株的强大选择压力。在农业中，抗生素作为生长促进剂在畜牧业和水产养殖中的使用将亚治疗浓度引入环境，在共生菌和环境细菌中选择耐药性。

Poor infection control in healthcare settings facilitates transmission of resistant organisms between patients. Global travel and trade allow resistant strains to cross borders rapidly. The antibiotic development pipeline has slowed dramatically： no new major class has been discovered since the 1980s. As resistance spreads to existing drugs, therapeutic options dwindle. The WHO has declared AMR a top ten global public health threat. 医疗环境中不良的感染控制措施促进了耐药菌在患者之间的传播。全球旅行和贸易使耐药菌株迅速跨越国界。抗生素研发管线已大幅放缓：自1980年代以来未发现新的主要类别。随着耐药性蔓延，治疗选择不断减少。WHO已将AMR列为全球十大公共卫生威胁之一。

10. Strategies to Combat Resistance

Combating antimicrobial resistance requires a multifaceted “One Health” approach integrating human medicine, veterinary medicine, and environmental stewardship. Antimicrobial stewardship programmes promote the prudent use of antibiotics ： prescribing the right drug at the right dose for the right duration. Diagnostic tests that rapidly distinguish bacterial from viral infections can reduce unnecessary antibiotic prescriptions. Combination therapy (using two or more antibiotics with different mechanisms of action) reduces the probability of resistance emerging, as a bacterium would need to acquire simultaneous mutations against all drugs. 对抗抗微生物耐药性需要一种多方面的”一体健康”方法，整合人类医学、兽医学和环境管理。抗菌药物管理计划促进抗生素的审慎使用：在正确的剂量下、在正确的疗程内使用正确的药物。快速区分细菌和病毒感染的诊断检测可以减少不必要的抗生素处方。联合治疗（使用两种或多种具有不同作用机制的抗生素）降低了耐药性出现的可能性，因为细菌需要同时获得针对所有药物的突变。

Novel therapeutic approaches are being explored. Bacteriophage therapy uses viruses that specifically infect and lyse bacteria. Antimicrobial peptides (AMPs) disrupt bacterial membranes and resist resistance development. CRISPR-Cas systems can be programmed to target and destroy resistance genes. Vaccination reduces infection incidence and antibiotic demand. At the policy level, banning agricultural growth-promoter antibiotics and investing in new drug discovery are critical. 新型疗法正在探索中。噬菌体疗法利用特异性裂解细菌的病毒。抗菌肽破坏细菌膜且不易耐药。CRISPR-Cas系统可编程靶向耐药基因。疫苗接种减少感染并降低抗生素需求。政策层面，禁止农业促生长抗生素和投资新药研发至关重要。

11. Exam Tips for A-Level Biology

When answering A-Level exam questions on antibiotics, it is essential to use precise terminology and explain mechanisms clearly. Describe the specific molecular target of the antibiotic rather than giving vague statements. For instance, rather than saying “penicillin kills bacteria by damaging the cell wall,” state that “penicillin irreversibly inhibits transpeptidase enzymes, preventing the cross-linking of peptidoglycan strands, which weakens the cell wall and causes osmotic lysis.” Link each mechanism to the broader principle of selective toxicity by explaining why the target is absent or different in human cells. 在回答A-Level考试中关于抗生素的问题时，使用精确的术语并清晰地解释机制至关重要。描述抗生素的具体分子靶点，而不是给出模糊的陈述。例如，不要说”青霉素通过破坏细胞壁杀死细菌”，而应表述为：”青霉素不可逆地抑制转肽酶，阻止肽聚糖链的交联，从而削弱细胞壁并导致渗透性裂解。”通过解释为什么该靶点在人类细胞中不存在或不同，将每个机制与选择性毒性的更广泛原则联系起来。

Common exam questions ask students to explain why antibiotics are ineffective against viruses (viruses lack bacterial targets such as cell walls, 70S ribosomes, and metabolic pathways), or to describe how resistance develops and spreads. Be prepared to discuss natural selection: antibiotics create a selection pressure, and bacteria with pre-existing resistance mutations survive and reproduce, passing resistance alleles to their offspring. Horizontal gene transfer accelerates spread across populations. Synoptic questions may link antibiotics to DNA replication, protein synthesis, enzyme inhibition, and cell structure. 常见考题要求学生解释为什么抗生素对病毒无效（病毒缺乏细胞壁、70S核糖体等细菌靶点），或描述耐药性如何产生和传播。准备好讨论自然选择：抗生素产生选择压力，携带耐药突变的细菌存活繁殖，传递耐药等位基因。水平基因转移加速耐药性在群体中的传播。综合性题目可能将抗生素与DNA复制、蛋白质合成和细胞结构等主题联系起来。

12. Summary

Antibiotics represent one of the triumphs of modern medicine, operating through selective toxicity mechanisms that exploit differences between prokaryotic and eukaryotic cells. From penicillins targeting cell wall synthesis to tetracyclines blocking protein synthesis, each class targets bacterial processes absent in humans. However, the rapid spread of antimicrobial resistance： mediated by enzymatic inactivation, target modification, and horizontal gene transfer： threatens to reverse a century of medical progress. Understanding these principles is essential for A-Level success and for appreciating a critical public health challenge. 抗生素是现代医学的胜利之一，通过选择性毒性机制利用原核与真核细胞间的差异。从青霉素靶向细胞壁合成到四环素阻断蛋白质合成，每类药物都靶向人类不存在的细菌过程。然而，抗微生物耐药性的快速传播：通过酶促灭活、靶点修饰和水平基因转移：威胁着逆转医学进步。理解这些原理对A-Level考试和认识公共卫生挑战都至关重要。